financetom
Business
financetom
/
Business
/
Canada's Scotiabank, BMO beat profit on capital markets, wealth management strength
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Canada's Scotiabank, BMO beat profit on capital markets, wealth management strength
Feb 25, 2025 4:34 AM

*

Strong income from capital markets and wealth management

boosts

profits

*

Banks set aside funds for bad loans amid trade tensions

*

Scotiabank expands in North America, divest Latin American

assets

Feb 25 (Reuters) - Canada's Bank of Nova Scotia ( BNS )

and Bank of Montreal ( BNKD ) on Tuesday beat analysts'

expectations for quarterly profit driven by strong income from

capital markets and wealth management businesses.

Lower interest rates have increased appetite for mergers and

acquisitions while less regulation, lower corporate taxes and a

broadly pro-business stance in Canada's southern neighbour are

expected to boost activity this year.

The wealth management business, a capital-light and

fee-based business, has also boomed recently, powered by a rise

in the number of high net worth individuals and increasing

investments.

The banks, Canada's third and fourth largest, still set

aside large sums to shield against bad loans in a challenging

environment amidst trade tensions between Canada and the United

States, a key market for the lenders.

U.S. President Donald Trump has threatened to impose a 25%

tariff on all non-energy Canadian imports starting in March.

Scotiabank said its provisions of C$1.16 billion ($813.81

million) were partly due to uncertainties related to the impact

of tariffs on Canada and Mexico. Analysts were expecting

provisions of C$1.12 billion, according to LSEG data.

"We are well positioned to compete and grow in this dynamic

operating environment," BMO's CEO Darryl White said in a

statement.

The lender, which had said its credit issues would normalize

in 2025, recorded provisions for credit losses of C$1.01

billion, lower than analysts' expectations of C$1.14 billion.

Both BMO and Scotiabank have looked for expansion

opportunities outside of the Canadian market, largely dominated

by the Big Six banks, entering markets in other parts of North

America.

BMO has expanded on the U.S. West Coast through its

acquisition of Bank of the West.

Under CEO Scott Thomson, Scotiabank changed focus to push

funding to stable, lower-risk countries, making a bet on the

North American trade corridor.

The plan focuses on growth closer to home, from the province of

Quebec to the United States and Mexico. As a part of the

strategy, Scotiabank sold its Colombia, Panama and Costa Rica

operations to Banco Davivienda and bought a roughly 15% stake in

U.S. regional lender KeyCorp ( KEY ).

On an adjusted basis, Scotiabank earned C$1.76 per share,

compared with analysts' estimates of C$1.65, according to LSEG

data.

It recorded an impairment charge of C$1.36 billion due to

the sale of Latin American assets.

BMO reported adjusted earnings of C$3.04 per share, beating

the average estimate of C$2.41.

($1 = 1.4254 Canadian dollars)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Toyota to build plant to produce EVs in China, Nikkei reports
Toyota to build plant to produce EVs in China, Nikkei reports
Dec 23, 2024
TOKYO, Dec 23 (Reuters) - Toyota Motor ( TM ) has decided to build a new factory to produce electric vehicles in China, the Nikkei business daily reported on Monday. The company will produce its luxury car brand Lexus at a new plant in Shanghai, the Nikkei reported citing several sources. Toyota ( TM ) has worked in China via...
Psyence Biomedical Expects to Raise $2 Million From Private Placement
Psyence Biomedical Expects to Raise $2 Million From Private Placement
Dec 23, 2024
08:40 AM EST, 12/23/2024 (MT Newswires) -- Psyence Biomedical ( PBM ) said Monday it has agreed to a private placement of 1 million common shares or pre-funded warrants, along with accompanying series A and series B warrants, priced at $2 each for expected gross proceeds of $2 million. The company said the series A warrants expire in five years,...
Nuvation Bio's Lung Cancer Drug Candidate Taletrectinib Gets FDA Priority Review
Nuvation Bio's Lung Cancer Drug Candidate Taletrectinib Gets FDA Priority Review
Dec 23, 2024
08:37 AM EST, 12/23/2024 (MT Newswires) -- Nuvation Bio ( NUVB ) said Monday the US Food and Drug Administration has accepted its new drug application for drug candidate taletrectinib intended for the treatment of non-small cell lung cancer. The FDA granted priority review and set a Prescription Drug User Fee Act goal date of June 23, Nuvation said. Nuvation...
Brazil's Petrobras to sign deal for four new support vessels built locally
Brazil's Petrobras to sign deal for four new support vessels built locally
Dec 23, 2024
RIO DE JANEIRO (Reuters) - Brazil's Transpetro, a unit of state-run oil firm Petrobras, said on Monday that local shipbuilding firms Ecovix and Mac Laren had won a tender to build four new coastal vessels for $69.5 million per vessel. WHY IT'S IMPORTANT The bid is the first step of Petrobras' plan to renew its fleet of support vessels, and...
Copyright 2023-2025 - www.financetom.com All Rights Reserved